HeavenlyDoor.com, Inc. is a publicly traded Internet company whose objectives are to provide products and services for the elderly and aging baby boomer population, with an initial focus on the pre-planning of funerals, and ultimately the long-term care, assisted living and financial/estate planning industries. The company, through its subsidiary d/b/a Procept, Inc., has licensed its biotechnology compound, PRO 2000 Gel to Interneuron Pharmaceuticals, Inc. (NASDAQ: IPIC - news) on June 15, 2000 and seeks to license its biotechnology compound, O6-Benzylguanine. Both of these biotechnology compounds have had substantial government support for their clinical trials to date.